Elite Pharma to release Q2 FY2026 results Nov 14; conference call Nov 17

ELITE PHARMACEUTICALS INC /NV/

Q2 FY2026 financial results (ended Sep 30, 2025) to be released on Friday, November 14, 2025.
Management conference call set for Monday, November 17, 2025, at 11:30 AM EST.
Dial-in numbers: 1-800-346-7359 (domestic), 1-973-528-0008 (international); conference ID 98840.
Stockholder questions accepted via email (dianne@elitepharma.com) by deadlines listed in release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.